Uroxatral (Alfuzosin Hydrochloride) - Indications and Dosage

INDICATIONS AND USAGE

UROXATRAL (alfuzosin HCl extended-release tablets) is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia. UROXATRAL is not indicated for the treatment of hypertension.

DOSAGE AND ADMINISTRATION

The recommended dosage is one 10 mg UROXATRAL (alfuzosin HCl extended-release tablets) tablet daily to be taken immediately after the same meal each day. The tablets should not be chewed or crushed.

HOW SUPPLIED

UROXATRAL (alfuzosin HCl extended-release tablets) 10 mg is available as a round, three-layer tablet: one white layer between two yellow layers, debossed with X10. UROXATRAL is supplied as follows:

Package	NDC Number
Bottles of 30	0024-4200-30
Bottles of 100	0024-4200-10
Hospital Unit Dose (blister packs containing 10 cards of 10 tablets each)	0024-4200-20

Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

Protect from light and moisture.

Keep UROXATRAL out of reach of children.